发明授权
US09078917B2 Extract of Phaleria macrocarpa as an antineoplastic, anti-inflammatory and antiangiogenic agent
有权
Phaleria macrocarpa的提取物作为抗肿瘤，抗炎和抗血管生成剂
- 专利标题： Extract of Phaleria macrocarpa as an antineoplastic, anti-inflammatory and antiangiogenic agent
- 专利标题（中）： Phaleria macrocarpa的提取物作为抗肿瘤，抗炎和抗血管生成剂
-
申请号： US12997171申请日： 2009-06-08
-
公开(公告)号： US09078917B2公开(公告)日： 2015-07-14
- 发明人: Raymond R. Tjandrawinata , Asep Aripin , Poppy Firzani Arifin , Dina Rahmi
- 申请人： Raymond R. Tjandrawinata , Asep Aripin , Poppy Firzani Arifin , Dina Rahmi
- 申请人地址： ID Palembang
- 专利权人： PT. Dexa Medica
- 当前专利权人： PT. Dexa Medica
- 当前专利权人地址： ID Palembang
- 代理机构： Neifeld IP Law, PC
- 优先权： IDP00200800334 20080616
- 国际申请： PCT/IB2009/052407 WO 20090608
- 国际公布： WO2009/153692 WO 20091223
- 主分类号： A61K36/00
- IPC分类号： A61K36/00 ; A61K36/83
摘要：
A pharmaceutical dosage form comprising an extract of Phaleria macrocarpa which has antineoplastic, anti-inflammatory, and antiangiogenic activity. Its use as an antineoplastic agent is to inhibit tumour growth. Its use as an anti-inflammatory agent is to relieve inflammation and pain, and also as an antipyretic. Another use is as an antiangiogenic agent to inhibit the growth of new blood vessels to prevent cancer metastasis.
公开/授权文献
信息查询
